{
  "doc_id": "9fbdb22ab94e8d5a48b084db9f4293be9dfc201b52f612e072dd7cdf2007dc7d",
  "chunk_entities": [
    {
      "chunk_id": "0ac0ee03b6482e35f463716271e4cf57",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "Schizophrenia",
          "context": "National Alliance for Research on Schizophrenia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Depression",
          "context": "Schizophrenia and Depression"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Aging",
          "context": "National Institute on Aging"
        }
      ]
    },
    {
      "chunk_id": "ed7d2cb88e7ca3cd0684ecc07797ef89",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "Adult male mice deficient in PDE4D"
        },
        {
          "entity_type": "Compound",
          "entity_name": "miRNA",
          "context": "lentiviral vector/microRNA (miRNA) microinfusions"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "2 g per mouse each day",
          "context": "food was restricted to 2 g per mouse each day"
        }
      ]
    },
    {
      "chunk_id": "d212ca5519e9a028ab0d666b2a141da8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram (1.25 mg/kg)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.25 mg/kg",
          "context": "rolipram (1.25 mg/kg)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Dimethyl sulfoxide",
          "context": "vehicle (5% DMSO)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "5% DMSO",
          "context": "vehicle (5% DMSO)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Bromodeoxyuridine",
          "context": "BrdU (100 mg/kg)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "100 mg/kg",
          "context": "BrdU (100 mg/kg)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Bromodeoxyuridine",
          "context": "BrdU (100 mg/kg)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "100 mg/kg",
          "context": "BrdU (100 mg/kg)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram or vehicle"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram or vehicle"
        }
      ]
    },
    {
      "chunk_id": "2f4e21b18a9e5d3025eeb4f765ecc955",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "miRNA",
          "context": "Lentiviral miRNA-mediated knock-down"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "silence PDE4D genes"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D miRNA",
          "context": "The sequence for the PDE4D miRNA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "shRNA-mir hairpin structure",
          "context": "PDE4D miRNA (shRNA-mir hairpin structure)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5'-AATGGAGTCACAATCAAGTCA-GTTTTGGCCACTGACTGACTGACTTGGAGTGACTCCATT-3'",
          "context": "The sequence for the PDE4D miRNA (shRNA-mir hairpin structure) was 5'-AATGGAGTCACAATCAAGTCA-GTTTTGGCCACTGACTGACTGACTTGGAGTGACTCCATT-3'"
        },
        {
          "entity_type": "Compound",
          "entity_name": "antisense target sequence",
          "context": "The bold sequence (first 21 nt) is the antisense target sequence"
        },
        {
          "entity_type": "Compound",
          "entity_name": "sense target sequence",
          "context": "The final sequence (italics) represents nt 1\u20138 and 11\u201321 of the sense target sequence"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nucleotides 642\u2013662",
          "context": "targets nucleotides 642\u2013662 of the rat PDE4D4 coding sequence"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rat PDE4D4 coding sequence",
          "context": "nucleotides 642\u2013662 of the rat PDE4D4 coding sequence"
        },
        {
          "entity_type": "Compound",
          "entity_name": "amino acids 214\u2013221",
          "context": "corresponds to amino acids 214\u2013221 within the UCR1 domain"
        },
        {
          "entity_type": "Compound",
          "entity_name": "UCR1 domain",
          "context": "amino acids 214\u2013221 within the UCR1 domain"
        },
        {
          "entity_type": "Compound",
          "entity_name": "long-form PDE4D",
          "context": "UCR1 domain of long-form PDE4D"
        }
      ]
    },
    {
      "chunk_id": "165dbd0e04ed8aef6590905685beaa08",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "NC sequence",
          "context": "the NC sequence from Invitrogen was 5'-GAAATGTACTGCCGTGGAGACGTTTTGGCCACTGACTGACG-TCTCCACGAGTACATTT-3'"
        },
        {
          "entity_type": "Compound",
          "entity_name": "5'-GAAATGTACTGCCGTGGAGACGTTTTGGCCACTGACTGACG-TCTCCACGAGTACATTT-3'",
          "context": "the NC sequence from Invitrogen was 5'-GAAATGTACTGCCGTGGAGACGTTTTGGCCACTGACTGACG-TCTCCACGAGTACATTT-3'"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4DmiR",
          "context": "In both 4DmiR and NC sequences"
        },
        {
          "entity_type": "Compound",
          "entity_name": "miR-155",
          "context": "came from the miR-155 hairpin loop"
        }
      ]
    },
    {
      "chunk_id": "1168c595b09ed861ba8bafbda5ba41bd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "ketamine",
          "context": "Mice were anesthetized with ketamine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "100 mg/kg",
          "context": "ketamine (100 mg/kg)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "xylazine",
          "context": "and xylazine"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "20 mg/kg",
          "context": "xylazine (20 mg/kg)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anesthetized",
          "context": "Mice were anesthetized"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "4 \u00d7 10^6 TU/\u00b5l",
          "context": "Lentiviral vectors (4 \u00d7 10^6 TU/\u00b5l"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 \u00b5l/side",
          "context": "1 \u00b5l/side)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NC",
          "context": "containing NC"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4DmiR",
          "context": "or 4DmiR"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.2 \u00b5l/min",
          "context": "at a rate of 0.2 \u00b5l/min"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "30 \u00b5m",
          "context": "coronal sections (30 \u00b5m)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "miRNAs",
          "context": "Expression of the miRNAs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "EGFP",
          "context": "indicated by EGFP"
        }
      ]
    },
    {
      "chunk_id": "f996e578d63fd99b16b14e839bea2353",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Rolipram",
          "context": "Rolipram was given"
        }
      ]
    },
    {
      "chunk_id": "791f229ba83b951e8d7a09abcd4f5d03",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "spatial memory",
          "context": "measure spatial memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "injection of rolipram"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.25 mg/kg",
          "context": "rolipram (1.25 mg/kg)"
        }
      ]
    },
    {
      "chunk_id": "a29497f0e5ebba2d8421f7f729c210c0",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "PDE4B (Huston et al., 1997) (1:1500)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:1500",
          "context": "PDE4B ... (1:1500)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D3",
          "context": "PDE4D3 (1:500)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:500",
          "context": "PDE4D3 (1:500)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D4",
          "context": "PDE4D4 (1:1000)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:1000",
          "context": "PDE4D4 (1:1000)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "PDE4D5 (1:500; FabGennix for all PDE4 antibodies"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:500",
          "context": "PDE4D5 (1:500;"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 antibodies",
          "context": "for all PDE4 antibodies"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\beta-actin",
          "context": "or \\beta-actin (inner control; 1:1000; Sigma)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:1000",
          "context": "\\beta-actin (inner control; 1:1000; Sigma)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "anti-\\beta-actin antibody",
          "context": "except for the anti-\\beta-actin antibody"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Alexa Fluor 700-conjugated goat anti-rabbit IgG",
          "context": "Alexa Fluor 700-conjugated goat anti-rabbit IgG (1:20,000; Invitrogen)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:20,000",
          "context": "IgG (1:20,000; Invitrogen)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "stripping buffer",
          "context": "stripping buffer (Millipore Bioscience Research Reagents)"
        }
      ]
    },
    {
      "chunk_id": "f63f6a66e20dccfcd49eb59b553665cc",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "immunofluorescent staining of BrdU"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PBS-plus",
          "context": "incubated for 1 d with cold PBS-plus"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rat anti-BrdU",
          "context": "contained rat anti-BrdU"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:200",
          "context": "rat anti-BrdU (1:200)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "polysialic acid neural cell adhesion molecule (PSA-NCAM)",
          "context": "mouse anti-polysialic acid neural cell adhesion molecule (PSA-NCAM)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:200",
          "context": "PSA-NCAM) (1:200)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "rabbit anti-pCREB"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:200",
          "context": "anti-pCREB (1:200)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "neuronal nuclei (NeuN)",
          "context": "mouse anti-neuronal nuclei (NeuN)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:1000",
          "context": "NeuN) (1:1000)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "S100\u03b2 antisera",
          "context": "rabbit anti-S100\u03b2 antisera"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:100",
          "context": "S100\u03b2 antisera (1:100)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PBS",
          "context": "rinsing with PBS"
        },
        {
          "entity_type": "Compound",
          "entity_name": "FITC-conjugated goat anti-rat IgG",
          "context": "incubated with FITC-conjugated goat anti-rat IgG"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:200",
          "context": "anti-rat IgG (1:200)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rhodamine Red-X-conjugated goat anti-rat IgG",
          "context": "Rhodamine Red-X-conjugated goat anti-rat IgG"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:200",
          "context": "anti-rat IgG (1:200)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "EGFP",
          "context": "distinguish EGFP from BrdU-labeled cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rhodamine Red-X-conjugated goat anti-mouse IgG",
          "context": "Rhodamine Red-X-conjugated goat anti-mouse IgG"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:200",
          "context": "anti-mouse IgG (1:200)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cy5-conjugated goat anti-rabbit IgG",
          "context": "Cy5-conjugated goat anti-rabbit IgG"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1:400",
          "context": "anti-rabbit IgG (1:400)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PBS",
          "context": "IgG in PBS for 2 h"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Vectashield medium",
          "context": "mounted with Vectashield medium"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PSA-NCAM",
          "context": "newborn neurons (PSA-NCAM immunopositive)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "among BrdU-labeled cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "examine pCREB in the newborn cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "labeled for both BrdU and PSA-NCAM"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PSA-NCAM",
          "context": "labeled for both BrdU and PSA-NCAM"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "50 BrdU-positive cells"
        }
      ]
    },
    {
      "chunk_id": "fcb70c544930593ee59b748aa2ea0402",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "with rolipram (1.25 mg/kg for 22 d)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.25 mg/kg for 22 d",
          "context": "rolipram (1.25 mg/kg for 22 d)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "greater recognition index",
          "context": "displayed a greater recognition index"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "PDE4D deficiency or rolipram treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram treatment increased the recognition index"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased the recognition index",
          "context": "increased the recognition index relative to WT mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "vehicle",
          "context": "treated with vehicle"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "effect of PDE4D deficiency"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "was not changed by rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "role of PDE4D in the mediation of memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mediation of memory",
          "context": "in the mediation of memory"
        }
      ]
    },
    {
      "chunk_id": "e4693f76589a3f3bd70d5332542332d5",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "chronic rolipram treatment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory-enhancing",
          "context": "memory-enhancing effects"
        }
      ]
    },
    {
      "chunk_id": "0fd72cf059cc2f2d94e15231c361ba87",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Increased hippocampal neurogenesis",
          "context": "Increased hippocampal neurogenesis in mice"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "deficient in PDE4D"
        }
      ]
    },
    {
      "chunk_id": "1f904006542ab20a3c04607ab538f6a1",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "BrdU-labeled cells"
        }
      ]
    },
    {
      "chunk_id": "3d9303599d0bdde16a47ed5293089cde",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "BrdU staining was carried out"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "double labeling for BrdU and NeuN"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NeuN",
          "context": "BrdU and NeuN, a neuronal marker"
        },
        {
          "entity_type": "Compound",
          "entity_name": "S100\\beta",
          "context": "or S100\\beta, a glial marker"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "BrdU-positive cells colocalized"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NeuN",
          "context": "both NeuN- and S100\\beta-labeled cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "S100\\beta",
          "context": "NeuN- and S100\\beta-labeled cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "Neither rolipram nor 4DKO altered"
        }
      ]
    },
    {
      "chunk_id": "35ccdab5610df6d9f2b539713669b711",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PSA-NCAM",
          "context": "express PSA-NCAM"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "coexpression of BrdU"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "and pCREB was examined"
        },
        {
          "entity_type": "Compound",
          "entity_name": "vehicle",
          "context": "treated with vehicle"
        }
      ]
    },
    {
      "chunk_id": "9530284bff511ceb09dea14b2c1257de",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "treated with vehicle (Veh) or rolipram (Rol)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "vehicle",
          "context": "treated with vehicle (Veh) or rolipram (Rol)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "show BrdU (green) labeling"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increases",
          "context": "Rolipram treatment significantly increases the number of BrdU-labeled cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "NeuN",
          "context": "double-labeled for BrdU (green) and NeuN (red)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "S100\u03b2",
          "context": "or S100\u03b2 (blue)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "does not alter",
          "context": "Rolipram treatment does not alter these percentages"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PSA-NCAM",
          "context": "triple-labeled for BrdU (green), PSA-NCAM (red)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "and pCREB (blue)"
        }
      ]
    },
    {
      "chunk_id": "13f924302131cc6e0a43cb5138a29642",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Vehicle",
          "context": "treated with Veh"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Roflumilast",
          "context": "treated with Rol"
        }
      ]
    },
    {
      "chunk_id": "b5918e7e87564c2a39f8216d9f26da0c",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "presence or absence of rolipram (Rol)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.25 mg/kg",
          "context": "Rolipram (1.25 mg/kg)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "once a day",
          "context": "injected (i.p.) once a day"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "26 d",
          "context": "once a day for 26 d"
        }
      ]
    },
    {
      "chunk_id": "8b35b3dc7e9cf3e6c3b70b496c25b4ef",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Rolipram",
          "context": "NC+Rol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Rolipram",
          "context": "4DmiR+Rol"
        }
      ]
    },
    {
      "chunk_id": "320c24f3b6040b604674e9a5c33a4bf6",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "lentiviral PDE4D-miRNA (4DmiR)",
          "context": "Effects of the lentiviral PDE4D-miRNA (4DmiR)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram (Rol)",
          "context": "with or without rolipram (Rol) treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "EGFP",
          "context": "indicated by EGFP (green"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D3",
          "context": "immunoblots of PDE4D3"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4D4",
          "context": "PDE4D3, 4D4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4D5",
          "context": "4D4, 4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4A5",
          "context": "4D5, 4A5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4B1",
          "context": "4A5, 4B1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4B4",
          "context": "4B1, and 4B4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "vehicle (Veh)",
          "context": "NC plus vehicle (Veh)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "4 \u00d7 10^6 TU/\u00b5l",
          "context": "4 \u00d7 10^6 TU/\u00b5l"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 \u00b5l per side",
          "context": "1 \u00b5l per side"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.25 mg/kg",
          "context": "rolipram treatment (1.25 mg/kg)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "once daily",
          "context": "injected (i.p.) once daily"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "16 d",
          "context": "once daily for 16 d"
        }
      ]
    },
    {
      "chunk_id": "5aab6d7a57888fdaad3b5d9b2a5c00d8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "Increases in pCREB"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D variants",
          "context": "downregulation of PDE4D variants"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Increases in pCREB",
          "context": "Increases in pCREB"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurogenesis",
          "context": "neurogenesis in the hippocampus"
        },
        {
          "entity_type": "Effect",
          "entity_name": "downregulation of PDE4D variants",
          "context": "downregulation of PDE4D variants"
        }
      ]
    },
    {
      "chunk_id": "021e34305ff46522cc1d9b996493a3d2",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "PDE4B) in the brain"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "brain of PDE4D-deficient mice"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory-enhancing effect",
          "context": "potentiate the memory-enhancing effect"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram did not alter memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "alter memory",
          "context": "rolipram did not alter memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "role of PDE4D in mediating memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "importance of PDE4D for memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "deficient in PDE4B"
        },
        {
          "entity_type": "Effect",
          "entity_name": "changes in memory",
          "context": "do not exhibit changes in memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D allosteric modulators",
          "context": "selective PDE4D allosteric modulators"
        },
        {
          "entity_type": "Compound",
          "entity_name": "scopolamine",
          "context": "reverse scopolamine-induced memory impairment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory impairment",
          "context": "scopolamine-induced memory impairment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhance memory",
          "context": "also enhance memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhanced hippocampal LTP",
          "context": "hippocampal LTP is enhanced"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "enhanced in PDE4D-deficient mice"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impaired fear-conditioning memory",
          "context": "fear-conditioning memory is unexpectedly impaired"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "increased expression of PDE4D"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "high doses",
          "context": "induced by high doses"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "high doses of PDE4 inhibitors"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impairs memory",
          "context": "PDE4 inhibitors impairs memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4A",
          "context": "role of PDE4A in memory"
        }
      ]
    },
    {
      "chunk_id": "ec99dde2a0992a8979bf6b46e170b5bc",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "PDE4-mediated cAMP/CREB signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "CREB",
          "context": "PDE4-mediated cAMP/CREB signaling"
        },
        {
          "entity_type": "Effect",
          "entity_name": "adult neurogenesis",
          "context": "regulation of adult neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "learning",
          "context": "associated with learning and memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory",
          "context": "associated with learning and memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "chronic treatment with rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "increased pCREB"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhanced memory",
          "context": "enhanced memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased BrdU-positive cells",
          "context": "increased BrdU-positive cells in the dentate gyrus"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "BrdU injections"
        },
        {
          "entity_type": "Effect",
          "entity_name": "survived",
          "context": "BrdU-labeled cells survived"
        },
        {
          "entity_type": "Effect",
          "entity_name": "proliferated",
          "context": "instead of proliferated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurogenic effect",
          "context": "The neurogenic effect of rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "PDE4D deficiency"
        },
        {
          "entity_type": "Effect",
          "entity_name": "survival",
          "context": "primarily survival"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "mice deficient in PDE4B"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cell proliferation",
          "context": "increase in cell proliferation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "survival of neurons",
          "context": "survival of neurons"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "major PDE4 subtype"
        },
        {
          "entity_type": "Effect",
          "entity_name": "hippocampal neurogenesis",
          "context": "responsible for hippocampal neurogenesis"
        }
      ]
    },
    {
      "chunk_id": "76b4df7d10c68af55640007f1e406fef",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Rolipram",
          "context": "Rolipram has been shown to increase hippocampal neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increase hippocampal neurogenesis",
          "context": "increase hippocampal neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increasing amplifying neural progenitors",
          "context": "by increasing amplifying neural progenitors (ANPs)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram increased expression of Sox2"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased hippocampal neurogenesis",
          "context": "At the dose that increased hippocampal neurogenesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "increased hippocampal neurogenesis and pCREB"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Sox2",
          "context": "increased expression of Sox2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "phenotype of BrdU-positive cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "PDE4D deficiency also increased hippocampal Sox2"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased hippocampal Sox2",
          "context": "increased hippocampal Sox2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "not altered by rolipram"
        },
        {
          "entity_type": "Compound",
          "entity_name": "BrdU",
          "context": "among BrdU-positive cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "PDE4D deficiency increases hippocampal neurogenesis"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increases hippocampal neurogenesis",
          "context": "increases hippocampal neurogenesis"
        }
      ]
    },
    {
      "chunk_id": "e31d4e6d9718af2e849e7be341701a6d",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "abnormal development",
          "context": "may lead to abnormal development"
        },
        {
          "entity_type": "Effect",
          "entity_name": "emesis",
          "context": "and emesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "miRNAs",
          "context": "we used miRNAs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "RNAi",
          "context": "one of the RNAi techniques"
        },
        {
          "entity_type": "Effect",
          "entity_name": "gene silencing",
          "context": "techniques for gene silencing"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4Ds",
          "context": "knock down the long-form PDE4Ds"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PKA",
          "context": "highly regulated by PKA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ERK",
          "context": "and ERK"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cAMP",
          "context": "intracellular cAMP hydrolysis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "siRNAs",
          "context": "by using siRNAs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B",
          "context": "variant of PDE4B"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "or PDE4D"
        },
        {
          "entity_type": "Compound",
          "entity_name": "lentivirus",
          "context": "used lentivirus as the vector"
        },
        {
          "entity_type": "Effect",
          "entity_name": "gene suppression",
          "context": "neuron-specific gene suppression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "EGFP",
          "context": "indicated by EGFP"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D4",
          "context": "long-form PDE4D4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "and PDE4D5 were selectively downregulated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "downregulated",
          "context": "were selectively downregulated"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurogenesis",
          "context": "increases in hippocampal neurogenesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "and pCREB levels"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhancement of memory",
          "context": "enhancement of memory"
        }
      ]
    },
    {
      "chunk_id": "5ba05933d043813d045fb63477b8c990",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4Ds",
          "context": "long-form PDE4Ds"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D7\u20139",
          "context": "PDE4D7\u20139"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D11",
          "context": "PDE4D7\u20139, 11"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D4/5",
          "context": "PDE4D4/5 variants"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4A5",
          "context": "PDE4A5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4A10",
          "context": "PDE4A10"
        }
      ]
    },
    {
      "chunk_id": "4c99a2a31283b54fc0089a974e152c14",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "chronic rolipram treatment"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D4",
          "context": "decreased expression of PDE4D4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4A5",
          "context": "A5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B1",
          "context": "B1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D3",
          "context": "increased expression of PDE4D3"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4B4",
          "context": "did not alter PDE4B4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "effects of rolipram"
        },
        {
          "entity_type": "Effect",
          "entity_name": "memory",
          "context": "effects of rolipram on memory"
        },
        {
          "entity_type": "Compound",
          "entity_name": "pCREB",
          "context": "memory, pCREB"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neurogenesis",
          "context": "pCREB, and neurogenesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D-miRNAs",
          "context": "combined rolipram and PDE4D-miRNAs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D4",
          "context": "role for PDE4D4"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D5",
          "context": "PDE4D5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4A5",
          "context": "PDE4A5"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4A10",
          "context": "PDE4A10"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4Ds",
          "context": "Other long-form PDE4Ds"
        },
        {
          "entity_type": "Compound",
          "entity_name": "4DmiR",
          "context": "effects of 4DmiR"
        }
      ]
    },
    {
      "chunk_id": "aadab4c160dabf3d3e795b15aba457e8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "PDE4D",
          "context": "downregulation of PDE4D"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\alpha 2 adrenergic receptor",
          "context": "\\alpha 2 adrenergic receptor-mediated anesthesia"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anesthesia",
          "context": "receptor-mediated anesthesia"
        },
        {
          "entity_type": "Disease",
          "entity_name": "emesis",
          "context": "measure of emesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "rolipram",
          "context": "rolipram treatment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anesthesia",
          "context": "duration of anesthesia"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4",
          "context": "contribution of PDE4"
        },
        {
          "entity_type": "Disease",
          "entity_name": "emesis",
          "context": "PDE4D to emesis"
        },
        {
          "entity_type": "Compound",
          "entity_name": "PDE4 inhibitors",
          "context": "side effect of PDE4 inhibitors"
        }
      ]
    }
  ],
  "total_entities": 268,
  "extraction_date": "2026-02-01T08:21:55.843815+00:00"
}